ConductScience.org, home

Paper37875111

Methotrexate-based PROTACs as DHFR-specific chemical probes.

Rana S and 16 others. Cell Chem Biol, 2024. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Methotrexate-based PROTACs as DHFR-specific chemical probes. Papers, record 37875111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37875111

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methotrexate-based PROTACs as DHFR-specific chemical probes.
PubMed
Journal
Cell Chem Biol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Intramural, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
2.9, provisional
iCite
Revised in PubMed
2026-09-03
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rana SSandeep
2Dranchak PPatricia
3Dahlin JLJayme L
4Lamy LLaurence
5Li WWenqing
6Oliphant EErin
7Shrimp JHJonathan H
8Rajacharya GHGirish H
9Tharakan RRavi
10Holland DODavid O
11Whitten ASApryl S
12Wilson KMKelli M
13Singh PKPankaj K
14Durum SKScott K
15Tao DDingyin
16Rai GGanesha
17Inglese JJames

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Folic Acid AntagonistsMajor topic
NeoplasmsMajor topic
Humans
Carbon
Methotrexate
Proteolysis Targeting Chimera
Tetrahydrofolate Dehydrogenase

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R43 TR000471NCATS NIH HHSUnited StatesR43TR000471PubMed and NIHNIH RePORTER
R01 CA256911NCI NIH HHSUnited StatesR01CA256911PubMed and NIHNIH RePORTER
R01 CA163649NCI NIH HHSUnited StatesR01CA163649PubMed and NIHNIH RePORTER
R01 CA270234NCI NIH HHSUnited StatesR01CA270234PubMed and NIHNIH RePORTER
Z01 BC009287Intramural NIH HHSUnited StatesZIABC009287PubMed and NIHNIH RePORTER
ZIA BC009287Intramural NIH HHSUnited StatesZIABC009287PubMed and NIHNIH RePORTER
ZIA TR000053Intramural NIH HHSUnited StatesZIATR000053PubMedNIH RePORTER
U54 CA274329NCI NIH HHSUnited StatesU54CA274329PubMed and NIHNIH RePORTER
ZIATR000471NIHNIH RePORTER
ZICTR000037NIHNIH RePORTER

Download CSV of grants

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136135Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase.Biochemistry1979https://conductscience.org/library/papers/36135PubMed
231715132A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo.Cancer Cell2019https://conductscience.org/library/papers/31715132PubMed
320129059Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ.Mol Cell2010https://conductscience.org/library/papers/20129059PubMed
417289560Chemical genetics: where genetics and pharmacology meet.Cell2007https://conductscience.org/library/papers/17289560PubMed
51167807Mechanism of growth inhibition by methotrexate.Cancer Res1975https://conductscience.org/library/papers/1167807PubMed
630444612Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation.J Am Chem Soc2018https://conductscience.org/library/papers/30444612PubMed
7565818Methotrexate analogues. 11. Unambiguous chemical synthesis and in vitro biological evaluation of alpha- and gamma-monoesters as potential prodrugs.J Med Chem1978https://conductscience.org/library/papers/565818PubMed
84213249Methotrexate analogs. 3. Synthesis and biological properties of some side-chain altered analogs.J Med Chem1974https://conductscience.org/library/papers/4213249PubMed
916572121A loss-of-function RNA interference screen for molecular targets in cancer.Nature2006https://conductscience.org/library/papers/16572121PubMed
1026051217Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4.Chem Biol2015https://conductscience.org/library/papers/26051217PubMed
1129772907Revisiting the "Art of the Chemical Probe".ACS Chem Biol2018https://conductscience.org/library/papers/29772907PubMed
1235779262RNA interference protocol to silence oncogenic drivers in leukemia cell lines.STAR Protoc2022https://conductscience.org/library/papers/35779262PubMed
1317429427ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?Leukemia2007https://conductscience.org/library/papers/17429427PubMed
147605998Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations.Blood1995https://conductscience.org/library/papers/7605998PubMed
152248959Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate.Biochemistry1990https://conductscience.org/library/papers/2248959PubMed
1635042991PROTAC targeted protein degraders: the past is prologue.Nat Rev Drug Discov2022https://conductscience.org/library/papers/35042991PubMed
1733707653Folate metabolism: a re-emerging therapeutic target in haematological cancers.Leukemia2021https://conductscience.org/library/papers/33707653PubMed
1833406420Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins.Cell Rep2021https://conductscience.org/library/papers/33406420PubMed
1917637769Reporting data from high-throughput screening of small-molecule libraries.Nat Chem Biol2007https://conductscience.org/library/papers/17637769PubMed
203278183The chemistry of methotrexate and its analogues.Med Res Rev1988https://conductscience.org/library/papers/3278183PubMed

See all 65 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42346097Structure-Based Virtual Screening and Mechanistic Characterization of Methotrexate and Selinexor as Potent Anti-Melanogenic Agents via Multi-Pathway Suppression of MITF.Cells2026https://conductscience.org/library/papers/42346097PubMed
42262317Engineering Protein Stability with Small Molecules: A Review of the ecDHFR Destabilizing Domain System.ACS Chem Biol2026https://conductscience.org/library/papers/42262317PubMed
42072629Label-Free Target Discovery Strategy for Natural Active Products.Biomolecules2026https://conductscience.org/library/papers/42072629PubMed
42009164Polyploid cancer cells surviving cisplatin reallocate central carbon sources to fuel antioxidant metabolism for survival.Mol Metab2026https://conductscience.org/library/papers/42009164PubMed
41950802Emerging mechanistic trends and clinical efficacy for methotrexate: Applications to inflammatory bowel disease.Pharmacol Rev2026https://conductscience.org/library/papers/41950802PubMed
41542490Drug-tolerant persister cells reallocate carbon sources to fuel antioxidant metabolism for survival.bioRxiv2026https://conductscience.org/library/papers/41542490PubMed
41502523ELK4 Promotes Vasculogenic Mimicry in Oral Squamous Cell Carcinoma via Driving DHFR Transcriptional Activation.Oncol Res2025https://conductscience.org/library/papers/41502523PubMed
41389337One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy.Cancer Metastasis Rev2025https://conductscience.org/library/papers/41389337PubMed
41155332New Insights into Pathogenesis and Management of Keratoacanthoma: A Narrative Review.Int J Mol Sci2025https://conductscience.org/library/papers/41155332PubMed
40626313Utilizing small molecules to probe and harness the proteome by pooled protein tagging with ligandable domains.Front Pharmacol2025https://conductscience.org/library/papers/40626313PubMed
40468924Innovative Therapies for Oncogenic KRAS Mutations: Precision Strategies with PROTACs in Cancer Treatment.Anticancer Agents Med Chem2026https://conductscience.org/library/papers/40468924PubMed
40346061A general assay platform to study protein pharmacology using ligand-dependent structural dynamics.Nat Commun2025https://conductscience.org/library/papers/40346061PubMed
40270992Combating Methotrexate Resistance in Cancer Treatment: A Review on Navigating Pathways and Enhancing Its Efficacy With Fat-Soluble Vitamins.Scientifica (Cairo)2025https://conductscience.org/library/papers/40270992PubMed
40045315An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma.J Nanobiotechnology2025https://conductscience.org/library/papers/40045315PubMed
39371335Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology.Front Med (Lausanne)2024https://conductscience.org/library/papers/39371335PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
DHFR1719PubTator's text mininghttps://conductscience.org/library/genes/1719

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37875111

GET https://conductscience.org/api/papers/v1/37875111/references?page=2